General Info

Humanetics is a privately held corporation focused on rapid discovery, development and commercialization of proprietary, orally administered, bioactive compounds for disease prevention and treatment. The company has an extensive patent portfolio and an active pipeline of compounds that range from discovery phase to human clinical trials. It is focused on three biotherapeutic areas with urgent and unmet needs immunodeficiency disorders, neurodegenerative diseases and metabolic dysfunction. All of Humanetics products are tested and proven safe for human use prior to being approved for sale. The company s products and newly discovered ingredients have been used in the dietary supplement, pharmaceutical and cosmetic industries. In 2005, Humanetics and the United States Department of Defense Medical School entered into a partnership agreement to develop countermeasures to protect against radiation exposure in the event of a terrorist attack. Humanetics is headquartered in Minneapolis.